Capital Securities. Each Equityholder agrees that it will not accept any Capital Securities of the Issuer or any rights or options to acquire any such Capital Securities, each in addition to or in substitution for the Issuer Pledged Collateral of such Equityholder, without prior written consent from the Trustee pursuant to Section 9.1 or Section 9.2 of the Indenture, as applicable, unless the foregoing are pledged to the Trustee pursuant hereto.
Appears in 2 contracts
Samples: Pledge and Security Agreement (Biocryst Pharmaceuticals Inc), Pledge and Security Agreement (PDL Biopharma, Inc.)
Capital Securities. Each The Equityholder agrees that it will not accept any Capital Securities of the Issuer or any rights or options to acquire any such Capital Securities, each in addition to or in substitution for the Issuer Pledged Collateral of such EquityholderCollateral, without prior written consent from the Trustee pursuant to Section 9.1 or Section 9.2 of the Indenture, as applicable, unless the foregoing are pledged to the Trustee pursuant hereto.
Appears in 2 contracts
Samples: Pledge and Security Agreement (Theravance Biopharma, Inc.), Pledge and Security Agreement (Theravance Biopharma, Inc.)
Capital Securities. Each Equityholder agrees that it will not accept any Capital Securities of the Issuer or other equity ownership interests, any rights or options to acquire any such Capital SecuritiesSecurities or other equity ownership interests or other securities, each in addition to or in substitution for the Issuer Pledged Collateral of such Equityholder, without prior written consent from the Trustee pursuant to Section 9.1 or Section 9.2 of the Indenture, as applicable, unless the foregoing are pledged to the Trustee pursuant hereto.
Appears in 1 contract
Samples: Pledge and Security Agreement (Indevus Pharmaceuticals Inc)
